Find the best answers to your questions with the help of IDNLearn.com's expert contributors. Join our Q&A platform to receive prompt and accurate responses from knowledgeable professionals in various fields.
A laboratory is conducting platelet aggregation tests on 2 samples: one from a patient on aspirin therapy and one from a healthy individual without any medication. Platelet-rich plasma from both samples is placed in a tube and light transmission is measured. Agonists, such as ADP and collagen, are added to each sample to induce platelet aggregation. When comparing the light transmission through these samples after the addition of platelet agonists, what is the expected observation? - In both samples, an equal amount of light will pass through regardless of treatment. - In the normal sample, more light passes through due to effective platelet aggregation. - In the aspirin - Treated sample, less light passes through due to reduced platelet aggregation. - Aspirin inhibits platelet aggregation, so more light passes through in the aspirin - Treated sample.
Sagot :
We greatly appreciate every question and answer you provide. Keep engaging and finding the best solutions. This community is the perfect place to learn and grow together. Find clear and concise answers at IDNLearn.com. Thanks for stopping by, and come back for more dependable solutions.
